[1]张 路,王 薇,王治国.国内两种允许总误差标准在评估临床化学检测项目分析质量及选择质控程序中的应用比较[J].现代检验医学杂志,2015,30(03):162-165.[doi:10.3969/j.issn.1671-7414.2015.03.050]
　ZHANG Lu,WANG Wei,WANG Zhi-guo.Application Comparison of Two Source of Allowable Total Errors in σ Metrics Assessing the Analytical Quality and Selecting Quality Control Procedures for Automated Clinical Chemistry[J].Journal of Modern Laboratory Medicine,2015,30(03):162-165.[doi:10.3969/j.issn.1671-7414.2015.03.050]
点击复制

国内两种允许总误差标准在评估临床化学检测项目分析质量及选择质控程序中的应用比较()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年03期
页码:
162-165
栏目:
质量控制·实验室管理
出版日期:
2015-06-10

文章信息/Info

Title:
Application Comparison of Two Source of Allowable Total Errors in σ Metrics Assessing the Analytical Quality and Selecting Quality Control Procedures for Automated Clinical Chemistry
文章编号:
1671-7414(2015)03-162-05
作者:
张 路1; 2; 王 薇2; 王治国2
1.北京协和医学院研究生院,北京 100730;
2.卫生部北京医院卫生部临床检验中心,北京 100730
Author(s):
ZHANG Lu1; 2; WANG Wei2; WANG Zhi-guo2
1.Graduate School of Peking Union Medical College,Beijing 100730,China;
2.National Center for Clinical Laboratories,Beijing Hospital,Beijing 100730,China
关键词:
允许总误差;  质量;  σ度量;  质控规则
分类号:
R446
DOI:
10.3969/j.issn.1671-7414.2015.03.050
文献标志码:
A
摘要:
目的 评估国内行业标准(WS/T 403-2012,临床生物化学检验常规项目分析质量指标)和国家标准(GB/T 20470-2006,临床实验室室间质量评价要求)提供的允许总误差在σ度量评估临床生化检测项目分析质量应用中的差异,用操作过程规范图(OPSpecs图)来选择适当的质控程序。方法 从卫生部临床检验中心2014年2月常规化学室内质控数据及2014年第一次常规化学室间质评中获得某一家实验室21个检测项目的变异系数(CV%)及百分差值(用其估计偏倚大小),利用国内行业标准(WS/T 403-2012)和国家标准(GB/T 20470-2006)提供的允许总误差计算两个批次质控品的σ值。使用临床检验定量测定室内质量控制设计软件(QCCS)绘制21个项目的操作过程规范图(OPSpecs图),根据该图选择质控程序。结果 使用国内行业标准(WS/T 403-2012)得到的σ值在0～7之间。而使用国家标准(GB/T 20470-2006)计算的σ值大多在3～15之间。在标准化方法决定图上,使用国家标准(GB/T 20470-2006)提供的允许总误差评估的试验分析性能普遍比使用国内行业标准(WS/T 403-2012)得到的高至少一个层级。使用国内行业标准(WS/T 403-2012)制定的质控程序明显比在国家标准(GB/T 20470-2006)下制定的质控程序严格。使用国内行业标准制定的质控程序中,多规则检测四次的有:ALB,ALP,Ca,Cl,TC,Crea,Glu,LDH,K,Na,TP,TG和Urea; 13 s检测四次的有:Mg; 12.5 s检测两次的有:CK,AMY和Fe; 13 s检测两次的有:TBIL; 13.5 s检测两次的有:ALT,AST和UA。结论 国内行业标准(WS/T 403-2012)提供的允许总误差较国内行业标准(WS/T 403-2012,临床生物化学检验常规项目分析质量指标)严格,临床实验室还需要不断提高其检测质量水平。
Abstract:
Objective To evaluate the difference of two sources of allowable total errors provided by National Health Industry Standard(WS/T 403-2012,analytical quality specification for routine analytes in clinicalbiochemistry)and National Standard(GB/T 20470-2006,requirements of externalquality assessment for clinical laboratories)in assessing the analytical quality by σ metrics,and selecting quality control procedures using operational process specifications graphs.Methods Selected one of the laboratories participating in the internal quality control activity of routine chemistry of February,2014 and the first time external quality assessment activityof routine chemistry in 2014 organized by National Center for Clinical Laboratories for its coefficient of variation and the bias of nineteen clinical chemistry tests.With the CV% and Bia%,σ metrics of controls at two analyte concentrations were calculated using two different allowable total errors targets(National Health Industry Standard(WS/T 403-2012)and National Standard(GB/T 20470-2006).Could obtain a operational process specifications graph by which Couldselect quality control procedures using the Quality control computer simulat software developed by National Center for Clinical Laboratories and the company zhongchuangyida.Results The σ metrics under National Health Industry Standard(WS/T 403-2012)were from 0 to 7.Most of the values(86%and 76.2%)under National Standard(GB/T 20470-2006)were from 3 to 15.On thenormalized method decision chart,the assay quality using the allowable total errors targets of National Standard(GB/T 20470-2006)was at least one hierarchymore than one using National Health Industry Standard(WS/T 403-2012).The quality control rules under National Health Industry Standard(WS/T 403-2012)wereobviously more strict than that under National Standard(GB/T 20470-2006).Among the control procedures using National Health Industry Standard(WS/T 403-2012),multirule(n=4):ALB,ALP,Ca,Cl,TC,Crea,Glu,LDH,K,Na,TP,TG andUrea; 13s(n=4):Mg; 12.5s(n=2):CK,AMY ang Fe; 13s(n=2):TBIL; 13.5s(n=2):ALT,AST and UA.Conclusion The allowable total errors provided by National Health Industry Standard(WS/T 403-2012)are more stringent than that from National Standard(GB/T 20470-2006).So Laboratories need to improve the analytical quality of their tests furthermore.

参考文献/References:

[1] Westgard JO.Six sigma quality design & control:desirable precision and requisite QC for laboratory measurement processes[M].Madison,WI:Westgard QC,2000.
[2] 王 薇,王治国,李少男.六西格玛在临床实验室的应用[J].中国医疗器械信息,2008,14(12):10-15,40.
Wang W,Wang ZG,Li SN.Application of the six Si-gma concept in clinical laboratories[J].China Medical Device Information,2008,14(12):10-15,40.
[3] Chesher D, Burnett L.Equivalence of critical error calculations and process capability index Cpk[J].Clin Chem,1997,43(6 Pt 1):1100-1101.
[4] 国家质量监督检验检疫总局.中国国家标准化管理委员会.WS/T403-2012.临床生物化学检验常规项目分析质量指标,第3部分:分析质量指标设定[S].北京:中国标准出版社,2013.
General Administrtion of Quality Supervision,Inspe-ctionand Quarantine of the People's Repabilc of China,Standardization Administration of China.WS/T403-2012,Analytical quality specification for routine ananlytes in clinical biochemistry,part 3:Define Analytical quality specification[S].Beijing:Standard Publishing of China,2013.
[5] 中华人民共和国国家质量监督检验检疫总局.中国国家标准化管量委员会.GB/T20470-2006.临床实验室室间质量评价要求,第5部分:各专业和亚专业室间质量评价计划的具体要求[S].北京:中国标准出版社,2006.
General Administration of Quality Supervision,Inspection and Quarantine of the People's Republic of China,Standardization Administration of the People's Republic of China.GB/T20470-2006.Requirements of external quality assessment for clinical laboratories,part 5:specific requirement of external quality assessment for different disciplines or sub disciplines[S].Beijing:Standard Publishing of China,2006.
[6] 中国合格评定国家认可委员会.CNAS-TRL-001.医学实验室-测量不确定度的评定与表达[M].北京:中国计量出版社,2012.
China National Accreditation Service for Conformity Assessmeet.CNAS-TRL-001.Medical Laboratory-evaluation and expression of measurement uncertainty[M].Beijing:China Metrology Press,2012.
[7] 王治国.临床检验质量控制技术[M].3版.北京:人民卫生出版社,2014:298-299.
Wang ZG.Quality control technology in clinical laboratory[M].3thEd.Beijing:People's Health Publishing House,2014:298-299.

相似文献/References:

[1]闫玉珠,王冀邯,赵和平.六西格玛质量管理规则在罗氏电化学发光免疫分析仪检测项目质量控制中的应用[J].现代检验医学杂志,2020,35(02):149.[doi:10.3969/j.issn.1671-7414.2020.02.041]
　YAN Yu-zhu,WANG Ji-han,ZHAO He-ping.Six Sigma Quality Management for Choosing Appropriate Quality ControlRules in Roche Electrochemical Luminescence Immunoanalyzer[J].Journal of Modern Laboratory Medicine,2020,35(03):149.[doi:10.3969/j.issn.1671-7414.2020.02.041]
[2]高自颖,何玲鸽,甄拴平.血清骨代谢标志物实验室检测基于生物学变异的允许总误差在可比性验证中的应用[J].现代检验医学杂志,2022,37(06):192.[doi:10.3969/j.issn.1671-7414.2022.06.037]
　GAO Zi-ying,HE Ling-ge,ZHEN Shuan-ping.Application of Allowable Total Error Based on Biological Variation in Comparability Verification of Serum Bone Metabolism Markers in Laboratory Detection[J].Journal of Modern Laboratory Medicine,2022,37(03):192.[doi:10.3969/j.issn.1671-7414.2022.06.037]

备注/Memo

备注/Memo:
作者简介:张 路(1989-),女,硕士研究生在读,研究方向,临床实验室质量管理,Tel:010-58115054,E-mail:zhanglu198989@126.com。
通讯作者:王治国,男,主任技师,E-mail:zgwang@nccl.org.cn。
更新日期/Last Update: 2015-06-10